Skip to content

Interest Paid at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$3.2M+18.5%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$2.21M0.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$20.12M+29.0%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$3.58M+51.0%
Biohaven logo
BiohavenBHVN
$54K+72.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$465.75M-2.5%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's interest paid?
Vera Therapeutics (VERA) reported interest paid of $1.63M in Q1 2026.
How has Vera Therapeutics's interest paid changed year-over-year?
Vera Therapeutics's interest paid increased by 3.2% year-over-year, from $1.58M to $1.63M.
What is the long-term trend for Vera Therapeutics's interest paid?
Over 3 years (2021 to 2025), Vera Therapeutics's interest paid has grown at a 633.9% compound annual growth rate (CAGR), from $17K to $6.72M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.